ePT--the Electronic Newsletter of Pharmaceutical Technology, Jun 7, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ePT--the Electronic Newsletter of Pharmaceutical Technology, Jun 7, 2012
News
Takeda Completes Acquisition of URL Pharma
By Amy Ritter
Takeda Pharmaceuticals announced that it has completed the acquisition of URL Pharma for an upfront payment of $800 million.
ISPE Issues Change-Management Guide
By Patricia Van Arnum
New guide outlines potential product life-cycle approaches to the change-management system of a pharmaceutical quality system.
USP Issues Change to Viscosity Reference in Monographs
By Susan Haigney
The United States Pharmacopeia has stated that references to General Chapter <911> "Viscosity" will be changed to General Chapter <911> "Viscosity—Capillary Viscometer Methods," <912> "Rotational Rheometer Methods," or <913> "Rolling Ball Viscometer Method."
Dr. Reddy's and Merck Serono Team Up on Biosimilars
By Stephanie Sutton
Dr. Reddy's Laboratories and Merck Serono, a division of Merck KGaA, have partnered to codevelop a portfolio of biosimilar compounds in oncology.
EMA Pharmacovigilance Legislation to Take Effect; New Q&A Document Offers Practical Guidance to Industry
By Jo Watts
In July 2012, new pharmacovigilance legislation will come into effect across the EU as a result of changes adopted in 2010, specifically EU Regulation No. 1235 and Directive 84.
Week of June 4, 2012: Catalent Expands Fill–Finish Capabilities; Siegfried Acquires Alliance Medical Products; and More
Catalent Expands Fill–Finish Capabilities; Siegfried Acquires Alliance Medical Products; and More.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
22%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
37%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here